Daejeon, South Korea

Won Mah

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Won Mah. Retrieved from https://idiyas.com/inventor/won-mah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Won Mah

Introduction

Won Mah is a prominent inventor based in Daejeon, South Korea. He has made significant strides in the field of neuroscience, particularly in developing methods to screen drugs for attention deficit hyperactivity disorder (ADHD). His innovative approach utilizes genetically modified mice to better understand and treat this condition.

Latest Patents

Won Mah holds a patent titled "Screening of drug for attention deficit hyperactive disorder by using GIT1 knock-out mice as a novel ADHD mouse model." This patent describes a method of using mammals, excluding humans, as models for ADHD. The method involves knocking out the genes of G protein-coupled receptor kinase interacting protein 1 (GIT1), which plays a crucial role in neuronal synapse function. The patent outlines how the analysis of GIT1 knock-out mice can be conducted in various biological aspects, including molecular, cellular, electrical biology, and animal behavior. The screening method allows for the observation of excessive behavior associated with ADHD and the recovery of theta wave activity in the frontal lobe upon administering candidate drug materials.

Career Highlights

Won Mah is affiliated with the Korea Advanced Institute of Science and Technology, where he conducts his research. His work has contributed to a deeper understanding of ADHD and the potential for new therapeutic approaches. His innovative methods have garnered attention in the scientific community, highlighting the importance of animal models in drug development.

Collaborations

Won Mah collaborates with esteemed colleagues, including Eunjin Kim and Changwon Kang. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field of ADHD.

Conclusion

Won Mah's contributions to the field of neuroscience through his innovative patent and research at the Korea Advanced Institute of Science and Technology are noteworthy. His work not only advances scientific understanding but also holds promise for developing effective treatments for ADHD.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…